What is 092730.KQ's gross margin?

NeoPharm (092730.KQ) has a gross margin of 67% and a net margin of 19%.

What is 092730.KQ's P/E ratio?

092730.KQ's P/E ratio is 11.8 with ROE of 16%.

Where can I see 092730.KQ's full financials?

See NeoPharm (092730.KQ) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

NeoPharm (092730.KQ) Financials — Revenue, Earnings, Cash Flow

Also trades as: 092730.KS (KSC) · $vol 0M

₩23,100.00 ($17.18)

-200.00 (-0.86%)

Weekly Expected Move ±5.0%

₩20781 ₩21940 ₩23100 ₩24260 ₩25419

KOE · Consumer Defensive · Household & Personal Products · Tech Score Buy · Power 49 · ₩361.3B mcap · 9M float · 0.711% daily turnover

Overview Chart Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers

📊 Key Metrics

TTM

₩148B

Revenue

+19.9% YoY

₩31B

Net Income

+21.3% YoY

₩28B

Free Cash Flow

+11.0% YoY

66.7%

Gross Margin

22.5%

Op. Margin

19.3%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE16.0%

ROA14.5%

ROIC44.5%

Valuation

P/E11.8

P/B1.8

EV/EBITDA3.7

Leverage

Debt/Equity0.01

Current Ratio7.53

Interest Cov.688.0x

Quality Scores

Piotroski F5/9

Altman Z9.91

Beneish M-1.90